Research programme: diabetic foot ulcer therapy - PLIVAAlternative Names: Diabetic foot ulcer therapy research programme - PLIVA; PLR-15
Latest Information Update: 16 Aug 2007
$50 / €47 *
At a glance
- Originator PLIVA d.d.
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic foot ulcer
Most Recent Events
- 20 Jul 2005 Preclinical trials in Diabetic foot ulcer in Europe (unspecified route)